Literature DB >> 24710759

Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis.

Tobias Lahmer1, Marlena Messer, Christiane Schwerdtfeger, Sebastian Rasch, Marcel Lee, Bernd Saugel, Roland M Schmid, Wolfgang Huber.   

Abstract

BACKGROUND: Severe alcoholic hepatitis (AH) has a poor short-term prognosis often caused by infections. However, the incidence of invasive mycosis in patients with AH treated with corticosteroids and its impact still remains unknown.
METHODS: Retrospective analyses of twelve medical ICU patients (out of 120 patients with liver cirrhosis) with histological proven AH.
RESULTS: Twelve patients were diagnosed with histological proven AH during there stay at the ICU. All patients were treated with corticosteroids; three patients were treated with corticosteroids and pentoxifylline. Five patients had invasive aspergillosis (IA); three patients had candidemia; and two had fungal colonization with candida species. Only two patients had no evidence for fungals. IA was associated with death in all cases. Death occured in most cases shortly after diagnosis despite antifungal medication. Two patients with candidemia died; one patient died in the group with fungal colonization. Overall, the mortality rate was 100% in patients with IA and 70% in the group with candidemia.
CONCLUSIONS: Patients with severe AH have an increased susceptibility to invasive mycosis associated with high mortality. A high level of suspicion of invasive mycosis in AH patients and prophylactic strategies are needed in those patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710759     DOI: 10.1007/s11046-014-9740-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  11 in total

1.  Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

Authors:  Philippe Mathurin; Charles L Mendenhall; Robert L Carithers; Marie-Jose Ramond; Willis C Maddrey; Peter Garstide; Bernard Rueff; Sylvie Naveau; Jean-Claude Chaput; Thierry Poynard
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

Review 2.  Management of bacterial infections in cirrhosis.

Authors:  Javier Fernández; Thierry Gustot
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

3.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

4.  Invasive aspergillosis in solid organ transplant recipients.

Authors:  N Singh; S Husain
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

Review 5.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

6.  Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis.

Authors:  Isabel Spriet; Wouter Meersseman; Pieter Annaert; Jan de Hoon; Ludo Willems
Journal:  Eur J Clin Pharmacol       Date:  2011-06-03       Impact factor: 2.953

Review 7.  Efficacy and safety of current drug therapies for invasive aspergillosis.

Authors:  Friederike Traunmüller; Martin Popovic; Karl-Heinz Konz; Freyja-Maria Smolle-Jüttner; Christian Joukhadar
Journal:  Pharmacology       Date:  2011-10-06       Impact factor: 2.547

Review 8.  Invasive aspergillosis in patients with liver disease.

Authors:  Marco Falcone; Anna Paola Massetti; Alessandro Russo; Vincenzo Vullo; Mario Venditti
Journal:  Med Mycol       Date:  2010-11-26       Impact factor: 4.076

9.  Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.

Authors:  Alexandre Louvet; Faustine Wartel; Hélène Castel; Sébastien Dharancy; Antoine Hollebecque; Valérie Canva-Delcambre; Pierre Deltenre; Philippe Mathurin
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

10.  Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series.

Authors:  Hélène Prodanovic; Christophe Cracco; Julien Massard; Camille Barrault; Dominique Thabut; Alexandre Duguet; Annick Datry; Jean-Philippe Derenne; Thierry Poynard; Thomas Similowski
Journal:  BMC Gastroenterol       Date:  2007-01-31       Impact factor: 3.067

View more
  9 in total

1.  Histopathological and Molecular Signatures of a Mouse Model of Acute-on-Chronic Alcoholic Liver Injury Demonstrate Concordance With Human Alcoholic Hepatitis.

Authors:  Shinji Furuya; Joseph A Cichocki; Kranti Konganti; Kostiantyn Dreval; Takeki Uehara; Yuuki Katou; Hisataka Fukushima; Hiroshi Kono; Igor P Pogribny; Josepmaria Argemi; Ramon Bataller; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

2.  Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort.

Authors:  Jasmohan S Bajaj; Rajender K Reddy; Puneeta Tandon; Florence Wong; Patrick S Kamath; Scott W Biggins; Guadalupe Garcia-Tsao; Michael Fallon; Benedict Maliakkal; Jennifer Lai; Hugo E Vargas; Ram M Subramanian; Paul Thuluvath; Leroy R Thacker; Jacqueline G OʼLeary
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

Review 3.  Infections in severe alcoholic hepatitis.

Authors:  Eleni Karakike; Christophe Moreno; Thierry Gustot
Journal:  Ann Gastroenterol       Date:  2016-10-27

Review 4.  Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.

Authors:  Siang Fei Yeoh; Tae Jin Lee; Ka Lip Chew; Stephen Lin; Dennis Yeo; Sajita Setia
Journal:  Infect Drug Resist       Date:  2018-05-30       Impact factor: 4.003

Review 5.  Infections in Cirrhosis.

Authors:  Sirina Ekpanyapong; K Rajender Reddy
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

Review 6.  Infections in Alcoholic Hepatitis.

Authors:  Bhupinder Kaur; Russell Rosenblatt; Vinay Sundaram
Journal:  J Clin Transl Hepatol       Date:  2022-05-06

Review 7.  Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions.

Authors:  Elda Righi
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742

Review 8.  Recent advances in alcoholic hepatitis.

Authors:  Vikrant Rachakonda; Ramon Bataller; Andres Duarte-Rojo
Journal:  F1000Res       Date:  2020-02-10

Review 9.  Fungal Infections in Liver Transplant Recipients.

Authors:  Michael Scolarici; Margaret Jorgenson; Christopher Saddler; Jeannina Smith
Journal:  J Fungi (Basel)       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.